Postradiation osteosarcoma in an older prostate cancer survivor: Case study and literature review with emphasis on geriatric principles

Keyphrases

• Older Adults 100%
• Osteosarcoma 100%
• Post-irradiation 100%
• Geriatrics 100%
• Prostate Cancer Survivors 100%
• Malignancy 66%
• Methotrexate 66%
• Clinical Trial Data 66%
• Comorbidity 33%
• Older Patients 33%
• Chemotherapy 33%
• Adverse Outcomes 33%
• Aging Population 33%
• Paucity 33%
• Cancer Treatment 33%
• Carboplatin 33%
• Acute Kidney Injury 33%
• Older Men 33%
• Therapeutic Potential 33%
• Young Males 33%
• Goals of Care 33%
• Age-related Illnesses 33%
• Neoadjuvant Chemotherapy 33%
• Local Recurrence 33%
• Second Primary Malignancy 33%
• Doxorubicin 33%
• Making Decisions 33%
• Cancer Survivors 33%
• Limb Sparing 33%
• Patient Preference 33%
• Localized Prostate Cancer 33%
• Cisplatin 33%
• Postoperative Course 33%
• Delirium 33%
• Elders 33%
• Hospice Care 33%
• Prior Cancer 33%
• Ilium 33%
• Limited Ability 33%
• Second Malignancy 33%
• Hemipelvectomy 33%
• Care of Older People 33%
• Geriatric Screening 33%
• Recurrent Hospitalization 33%
• Functional Independence 33%
• External Beam Radiation Therapy 33%

Medicine and Dentistry

• Cancer 100%
• Prostate Cancer 100%
• Geriatrics 100%
• Osteosarcoma 100%
• Clinical Trial 66%
• Second Cancer 66%
• Methotrexate 66%
• Cancer Therapy 33%
• Malignant Neoplasm 33%
• Clinician 33%
• Adverse Outcome 33%
• Limb 33%
• Recurrent Disease 33%
• Carboplatin 33%
• External Beam Radiotherapy 33%
• Acute Kidney Injury 33%
• Cisplatin 33%
• Neoadjuvant Chemotherapy 33%
• Doxorubicin 33%
• Patient Preference 33%
• Delirium 33%
• Geriatric Syndrome 33%
• Geriatric Assessment 33%
• Hemipelvectomy 33%
• Comorbidity 33%
• Chemotherapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Osteosarcoma 100%
• Clinical Trial 66%
• Malignant Neoplasm 66%
• Chemotherapy Regimens 66%
• Methotrexate 66%
• Second Cancer 66%
• Adverse Outcome 33%
• Recurrent Disease 33%
• Syndrome 33%
• Acute Kidney Failure 33%
• Cisplatin 33%
• Carboplatin 33%
• Doxorubicin 33%
• Delirium 33%
• Comorbidity 33%